China Nepstar Chain Drugstore (China Nepstar Chain Drugstore) Growth Rank : 0 (As of Jun. 16, 2024)

View and export this data going back to 2007. Start your Free Trial

What is China Nepstar Chain Drugstore Growth Rank?

China Nepstar Chain Drugstore has the Growth Rank of 0.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

China Nepstar Chain Drugstore Growth Rank Related Terms

Thank you for viewing the detailed overview of China Nepstar Chain Drugstore's Growth Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

China Nepstar Chain Drugstore (China Nepstar Chain Drugstore) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » China Nepstar Chain Drugstore Ltd (NYSE:NPD) » Definitions » Growth Rank

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.nepstar.cn

China Nepstar Chain Drugstore Ltd was incorporated in the Cayman Islands in August 2004. The Company operates retail drugstore business. The Company provides professional and convenient pharmacy services and other merchandise, including over-the-counter drugs, nutritional supplements, herbal products, personal care products, family care products, as well as convenience products including consumable, seasonal and promotional items. It also offers private label products. The Company offers 523 nutritional supplements, including a variety of healthcare supplements, vitamins, minerals and dietary products. Its other products include personal care products such as skin care, hair care and beauty products, family care products such as portable medical devices for family use, birth control and early pregnancy test products, and convenience products, including soft drinks, packaged snacks, cleaning agents and stationery. The other products also include seasonal and promotional items tailored to local consumer demand for convenience and quality. The Company also provides ancillary services such as providing free blood pressure measurements in its stores. The Company competes with other retail drugstore chains or independent drugstores. As a distributor and retailer of pharmaceutical products, the Company is subject to regulation and oversight by different levels of the food and drug administration in China, in particular, the State Food and Drug Administration, or the SFDA.

China Nepstar Chain Drugstore (China Nepstar Chain Drugstore) Headlines

From GuruFocus

High Yield George Soros Stocks: China Nepstar ADS, Chimera Investment, PDL BioPharma, MFA Mortgage Investments, Windstream Corp.

By Buffetteer Buffetteer • 04-23-2010